Navigation Links
AAIPharma Expands Laboratory Service Offerings and Capabilities in its Technology Center

WILMINGTON, N.C., Jan. 22, 2013 /PRNewswire/ -- AAIPharma Services Corp. ("AAIPharma"), a leading provider of pharmaceutical product development services, announced today the expansion of laboratory service offerings, capabilities and instrumentation in its state-of-the-art laboratory Technology Center in Wilmington, N.C. 


Following the company's opening of its Technology Center in May, 2012, AAIPharma has continued investing in its service offerings and acquired additional instrumentation to support its analytical and biopharmaceutical development laboratories.    

"AAIPharma specializes in comprehensive service offerings and offers the latest in instrumentation for our clients," said Patrick Walsh , chief executive officer of AAIPharma. "Since its grand opening, the Technology Center has been recognized for its modern, efficient operations and has exceeded client expectations as a world class laboratory."

AAIPharma continues to focus on serving clients' needs and has added new ICP-MS, GC-MS, LC-MS, UPLC and HPLC systems to its expansive list of instrumentation and capabilities to meet growing market demands. A Malvern™ Mastersizer 3000 particle size analyzer was added to support preformulation and material testing services. 

The company expanded its biopharmaceutical development services by adding a ProteinSimple MFI™5200 micro-flow imaging system, a Wyatt Dawn ® Heleos®II multi-angle laser light scattering (MALS) detector and a Wyatt DynaPro NanoStar dynamic light scattering (DLS) detector to support aggregate and particulate testing services.  A ProteinSimple iCE3 capillary IEF was added to further support protein analyses.

AAIPharma also expanded its extractable and leachable (E&L) testing services to evaluate and qualify the materials used in the manufacturing process and final product configuration. AAIPharma's subject matter experts already provide exceptional E&L testing services, and new capabilities include a Foss Soxtec™ 2050 automated extraction system to enable reproducible and robust methodologies.

About AAIPharma Services Corp. 

AAIPharma Services Corp. is a leading provider of contract services that support all phases of drug development. The company's wide array of capabilities includes analytical chemistry, formulation development, material testing services, microbiology, clinical and commercial contract manufacturing, pharmaceutical packaging, and stability services. Serving more than 600 clients around the globe and headquartered in Wilmington, N.C., AAIPharma is a portfolio company of Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care.

For more information on the company, visit

Related Links:

AAIPharma's Analytical Development Capabilities

AAIPharma's Biotechnology, Biopharmaceutical and Structural Chemistry Capabilities

AAIPharma News and Events:

AAIPharma Home Page:

SOURCE AAIPharma Services Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AAIPharma Appoints Director Of Analytical Chemistry
2. AAIPharma Appoints Senior Director of Biopharmaceutical Development
3. AAIPharma Announces Promotion Of Dean Shirazi To EVP Of Analytical Laboratories
4. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
5. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
6. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
7. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
8. S1 Biopharma Expands Focus to Include Male Sexual Health
9. PRA Expands Operations in Europe
10. USANA Health Sciences Expands Award-Winning Research and Development Team
11. Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films
Post Your Comments:
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):